(Q34041295)

30 July 2017

Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease (English)

1 reference

30 July 2017

0 references

H Keino

1

1 reference

30 July 2017

A A Okada

series ordinal

2

1 reference

30 July 2017

T Watanabe

series ordinal

3

1 reference

30 July 2017

W Taki

series ordinal

4

1 reference

30 July 2017

20 June 2014

1 reference

30 July 2017

1 reference

30 July 2017

28

1 reference

30 July 2017

9

1 reference

30 July 2017

1100-1106

1 reference

https://scigraph.springernature.com/pub.10.1038/eye.2014.138

30 July 2017

0 references

cites work

Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166631

Behçet's disease: general concepts and recent advances

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166631

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166631

Current concepts in the etiology and treatment of Behçet disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166631

Ocular immunopathology of Behçet's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166631

Uveitis in Behçet's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166631

Best-corrected visual acuity and frequency of ocular attacks during the initial 10 years in patients with Behçet's disease

5 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2014.138

Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2014.138

Multicenter study of infliximab for refractory uveoretinitis in Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2014.138

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2014.138

Birdshot retinochoroidopathy: ocular complications and visual impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2014.138

A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet's disease: a comparative 4-week study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2014.138

Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166631

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4166631

Fundus changes associated with Behçet's disease

28 October 2018

1 reference

12 December 2020

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

12 December 2020

1 reference

12 December 2020

Long-term safety and efficacy of infliximab therapy in refractory uveitis due to Behçet's disease

1 reference

12 December 2020

Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study

1 reference

12 December 2020

Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies

1 reference

12 December 2020

Acquired resistance to infliximab against uveitis due to Behçet's disease after one year of administration

1 reference

12 December 2020

Timing of recurrent uveitis in patients with Behcet's disease receiving infliximab treatment

1 reference

12 December 2020

Decreased ocular inflammatory attacks and background retinal and disc vascular leakage in patients with Behcet's disease on infliximab therapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/EYE.2014.138

1 reference

Dimensions Publication ID

30 July 2017

1050988443

0 references

Fatcat ID

release_v7oqxlkegjct5jx2by6y4ivda4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v7oqxlkegjct5jx2by6y4ivda4

24 November 2022

mapped directly with Wikidata item

PMCID

4166631

1 reference

30 July 2017

1 reference